Investigation on Safety, Tolerability and Bioavailability of Oral Semaglutide in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Semaglutide (Primary) ; Semaglutide (Primary) ; Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 15 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 14 Jan 2010 Results of this trial are expected in 2011, according to a Novo Nordisk media release.